V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001332 | 330000753 | 1.82 | null | Curative (C) | null | 2013-12-11 | Cisplatin | N | N | 330003359 | CISPLATIN |
| 330001333 | 330000754 | 0 | 78.5 | Palliative (P) | null | 2015-04-08 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330003362 | NOT MATCHED |
| 330001334 | 330000754 | null | 109.2 | Curative (C) | 2016-09-21 | 2016-09-21 | EW EuroEwing 2012 Arm A VAC | Y | null | 330003362 | NOT MATCHED |
| 330001335 | 330000755 | 1.73 | 44.4 | null | 2016-08-18 | 2016-09-16 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330003375 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001336 | 330000755 | null | 106 | Curative (C) | 2016-02-20 | 2016-02-25 | Trial Unspecified | N | N | 330003375 | TRIAL |
| 330001337 | 330000755 | 0 | 9.1 | Curative (C) | 2017-12-17 | 2017-12-17 | EW EuroEwing 2012 Arm B VDC | 2 | N | 330003375 | TRIAL |
| 330001338 | 330000755 | 1.65 | null | Curative (C) | 2016-01-10 | 2016-02-07 | Cisplatin | N | Y | 330003375 | CISPLATIN |
| 330001339 | 330000755 | null | 68.6 | Curative (C) | 2017-06-22 | 2017-06-23 | NB HRNBL | 1 | N | 330003375 | NOT MATCHED |
| 330001340 | 330000756 | null | 21 | Curative (C) | 2014-06-04 | 2014-06-07 | OST Euramos 1 Closed Trial - Ai | N | N | 330003386 | NOT MATCHED |
| 330001341 | 330006454 | 1.77 | null | null | 2013-11-22 | 2013-11-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003388 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001342 | 330000757 | 1.8 | 64.7 | Curative (C) | 2015-10-24 | 2015-11-07 | Cisplatin 7 day | N | Y | 330003390 | CISPLATIN |
| 330001343 | 330000758 | 1.7 | 89 | Curative (C) | 2017-02-13 | 2017-03-13 | Cisplatin 7 day | 2 | Y | 330003391 | CISPLATIN |
| 330001344 | 330000758 | null | 15.1 | Neo-adjuvant (N) | null | 2016-04-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330003391 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001345 | 330000759 | 0 | 18 | Curative (C) | 2016-11-29 | 2016-11-29 | NB Low/Interm risk guidelines Carbo/Etop | null | null | 330003396 | NOT MATCHED |
| 330001346 | 330000759 | 0 | 54.4 | Curative (C) | 2016-08-10 | 2016-08-16 | NB Low/Interm risk guidelines Carbo/Etop | N | null | 330003396 | NOT MATCHED |
| 330001347 | 330009494 | 1.82 | 68.6 | Curative (C) | null | 2015-07-17 | Cisplatin | N | N | 330003401 | CISPLATIN |
| 330001348 | 330000760 | 1.8 | 67.6 | Neo-adjuvant (N) | 2017-07-05 | 2017-07-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330003402 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001349 | 330006457 | 1.8 | 54.7 | Curative (C) | null | 2017-07-15 | Cisplatin | N | Y | 330003404 | CISPLATIN |
| 330001350 | 330000761 | 1.57 | 84.1 | Curative (C) | 2014-01-27 | 2014-02-13 | Cisplatin | 02 | N | 330003405 | CISPLATIN |
| 330001351 | 330000762 | 1.62 | 74 | Curative (C) | 2016-04-19 | 2016-05-23 | Cisplatin 7 day | N | Y | 330003406 | CISPLATIN |
| 330001352 | 330000763 | 1.56 | 8.4 | null | 2013-02-17 | 2013-03-15 | Cisplatin 7 day | 02 | null | 330003407 | CISPLATIN |
| 330001353 | 330000763 | 1.83 | null | Curative (C) | 2014-05-16 | 2014-05-21 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003407 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001355 | 330000765 | 1.7 | 95 | null | 2017-02-09 | 2017-02-13 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330003424 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001356 | 330000766 | null | null | Palliative (P) | 2015-08-15 | 2015-09-14 | Cisplatin 7 day | 02 | N | 330003426 | CISPLATIN |
| 330001357 | 330000767 | 1.76 | 82 | Curative (C) | 2014-04-11 | 2014-04-11 | Trial Unspecified | Y | N | 330003428 | TRIAL |
| 330001358 | 330000768 | 1.79 | null | Radical (R) | 2013-08-31 | 2013-09-07 | Cisplatin | null | Y | 330003429 | CISPLATIN |
| 330001359 | 330006459 | 1.61 | null | Curative (C) | 2015-01-08 | 2015-01-13 | Cisplatin | 02 | Y | 330003436 | CISPLATIN |
| 330001360 | 330000769 | 1.68 | 73.4 | Neo-adjuvant (N) | 2014-04-26 | 2014-04-28 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003438 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001361 | 330000769 | 1.6 | 80.4 | Curative (C) | 2013-09-06 | 2013-09-13 | Cisplatin 7 day | N | N | 330003438 | CISPLATIN |
| 330001362 | 330000769 | null | 49.2 | Curative (C) | 2013-07-30 | 2013-07-31 | LCH guideline Gp 1,2+3 IT - C1 | Y | N | 330003438 | NOT MATCHED |
| 330001363 | 330000769 | 1.68 | 48 | Curative (C) | 2017-07-31 | 2017-08-11 | Trial Unspecified | Y | N | 330003438 | TRIAL |
| 330001364 | 330000770 | 1.7 | 65.5 | Curative (C) | 2014-07-03 | 2014-07-04 | OST Euramos 1 Closed Trial - Ai | N | N | 330003453 | NOT MATCHED |
| 330001365 | 330000771 | 1.67 | 88 | Curative (C) | 2015-10-22 | 2015-10-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | null | 330003458 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001366 | 330000771 | 1.51 | 28 | Neo-adjuvant (N) | 2017-09-21 | 2017-09-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 330003458 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001367 | 330009496 | 1.7 | 14.6 | null | null | 2013-11-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330003461 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001368 | 330000772 | 1.59 | 36.7 | Curative (C) | 2017-02-02 | 2017-02-11 | Cisplatin | N | N | 330003463 | CISPLATIN |
| 330001369 | 330000773 | 1.61 | 58.8 | Curative (C) | 2016-06-08 | 2016-06-17 | Cisplatin | N | Y | 330003466 | CISPLATIN |
| 330001372 | 330000775 | 1.69 | 56.3 | Curative (C) | 2013-04-27 | 2013-05-25 | Cisplatin | N | N | 330003474 | CISPLATIN |
| 330001373 | 330000776 | 1.51 | null | Palliative (P) | null | 2016-03-03 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330003475 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001374 | 330000776 | 1.78 | 50.9 | Neo-adjuvant (N) | null | 2013-10-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003475 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001375 | 330000776 | null | 69.3 | Curative (C) | 2016-08-06 | 2016-08-07 | CYTARABINE + DAUNORUBICIN + VINCRISTINE | 02 | N | 330003475 | NOT MATCHED |
| 330001376 | 330000776 | 0 | 63.6 | Disease modification (D) | 2016-12-26 | 2017-01-01 | Trial Unspecified | null | N | 330003475 | TRIAL |
| 330001377 | 330000776 | 0 | null | Curative (C) | 2018-01-19 | 2018-01-19 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | Y | N | 330003475 | NOT MATCHED |
| 330001378 | 330000776 | 1.57 | 83.3 | Neo-adjuvant (N) | 2013-10-27 | 2013-11-18 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330003475 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001379 | 330000777 | null | null | Neo-adjuvant (N) | 2016-06-27 | 2016-07-01 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330003490 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001380 | 330000778 | 0 | 74.8 | Curative (C) | 2014-04-27 | 2014-05-05 | WT SIOP 2002 01 post op Carbo, Etop | N | N | 330003495 | NOT MATCHED |
| 330001381 | 330000779 | null | 21.4 | Palliative (P) | 2014-06-10 | 2014-06-10 | OST Euramos 1 Closed Trial - Ai | null | Y | 330003496 | NOT MATCHED |
| 330001382 | 330000780 | 1.6 | 78.65 | Neo-adjuvant (N) | 2014-06-10 | 2014-06-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 330003503 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001383 | 330000781 | 0 | 58 | Curative (C) | 2018-04-28 | 2018-05-06 | Rucaparib | Y | null | 330003504 | TRIAL |
| 330001384 | 330000782 | null | null | null | 2017-07-30 | 2017-09-10 | Cisplatin | N | N | 330003505 | CISPLATIN |